Blocking Tumor Necrosis Factor in Ankylosing Spondylitis

计划入组 42 人 · 首次发布于 2000 年 1 月 19 日

Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

计划入组 11 人 · 首次发布于 2015 年 5 月 29 日

Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response

计划入组 47 人 · 首次发布于 2013 年 11 月 3 日

Adalimumab biosimilar (Eastern Biotech)

Adalimumab(Amjevita, Cyltezo, Humira, Hyrimoz, Yusimry, Hulio, Hefiya, Libmyris, Imraldi, Amsparity, Idacio, Hukyndra, Amgevita, Yuflyma, Halimatoz)

Rx

Infliximab(Avsola, Flixabi, Inflectra, Remicade, Renflexis, Zessly, Remsima)

Rx

MAGNESIUM FACTOR PTY LTD

Australia

Stiftung Swiss Tumor Institute

Switzerland

Novel Anti-Infective Technologies, LLC

Biosimilar Switch in JIA Patients Shows Comparable Outcomes to Originator Maintenance

Johnson & Johnson Discontinues Nipocalimab Combination Therapy for Rheumatoid Arthritis After Phase 2a Trial Fails to Show Added Benefit

Tildrakizumab Demonstrates Sustained Safety Profile Over Four Years in Psoriatic Arthritis Extension Study